RxNorm Semantic Concepts Index - 423
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "423".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 423 | ajmaline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 423 | ajmaline | Designated preferred name (PT) | NO | |
RxCUI: 423 | ajmaline | Full form of descriptor (FN) | NO | |
RxCUI: 4230 | Eye Drops | Dose Form Entry Term (ET) | Entry terms for dose forms (TTY=DF). | NO |
RxCUI: 4230 | Eye Drops | Dose Form Entry Term (ET) | Entry terms for dose forms (TTY=DF). | NO |
RxCUI: 423000 | trolamine salicylate 70 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423002 | camphor 8.5 MG/ML / menthol 10 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423005 | titanium dioxide 24 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423008 | titanium dioxide 22 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423009 | titanium dioxide 101 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423063 | coal tar 50 MG/ML / salicylic acid 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423071 | erythromycin 47 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423074 | fluocortolone caproate 2.5 MG/ML / fluocortolone pivalate 2.5 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423136 | titanium dioxide 27 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423142 | cetrimide 7 MG/ML / chlorhexidine 7.5 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42316 | Tacrolimus | Full form of descriptor (FN) | YES | |
RxCUI: 42316 | Tacrolimus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 42316 | Tacrolimus | Designated preferred name (PT) | YES | |
RxCUI: 42316 | Tacrolimus | Full form of descriptor (FN) | YES | |
RxCUI: 42316 | Tacrolimus | Designated preferred name (PT) | YES | |
RxCUI: 42319 | Nizatidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 42319 | Nizatidine | Designated preferred name (PT) | YES | |
RxCUI: 42319 | Nizatidine | Full form of descriptor (FN) | YES | |
RxCUI: 42319 | Nizatidine | Designated preferred name (PT) | YES | |
RxCUI: 42319 | Nizatidine | Full form of descriptor (FN) | YES | |
RxCUI: 423207 | aluminum chlorohydrate 200 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423214 | lanolin 50 MG/ML / silicones 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42322 | Fleroxacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 42322 | Fleroxacin | Designated preferred name (PT) | NO | |
RxCUI: 42322 | Fleroxacin | Full form of descriptor (FN) | NO | |
RxCUI: 42322 | Fleroxacin | Designated preferred name (PT) | NO | |
RxCUI: 42322 | Fleroxacin | Full form of descriptor (FN) | NO | |
RxCUI: 42323 | Crack cocaine | Designated preferred name (PT) | NO | |
RxCUI: 42323 | Crack cocaine | Full form of descriptor (FN) | NO | |
RxCUI: 42323 | Crack cocaine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42323 | Crack cocaine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 423275 | gamma-aminobutyric acid 50 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42328 | Astemizole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 42328 | Astemizole | Designated preferred name (PT) | NO | |
RxCUI: 42328 | Astemizole | Full form of descriptor (FN) | NO | |
RxCUI: 42328 | Astemizole | Designated preferred name (PT) | NO | |
RxCUI: 42328 | Astemizole | Full form of descriptor (FN) | NO | |
RxCUI: 423281 | aminoquinuride 5 MG/ML / tetracaine 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423289 | piracetam 200 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423290 | piracetam 0.2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423291 | piracetam 125 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42330 | Terfenadine | Full form of descriptor (FN) | NO | |
RxCUI: 42330 | Terfenadine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 42330 | Terfenadine | Designated preferred name (PT) | NO | |
RxCUI: 42330 | Terfenadine | Full form of descriptor (FN) | NO | |
RxCUI: 42330 | Terfenadine | Designated preferred name (PT) | NO | |
RxCUI: 42331 | Misoprostol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 42331 | Misoprostol | Designated preferred name (PT) | YES | |
RxCUI: 42331 | Misoprostol | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 42331 | Misoprostol | Full form of descriptor (FN) | YES | |
RxCUI: 42331 | Misoprostol | Designated preferred name (PT) | YES | |
RxCUI: 42331 | Misoprostol | Full form of descriptor (FN) | YES | |
RxCUI: 42333 | Trimetrexate | Full form of descriptor (FN) | NO | |
RxCUI: 42333 | Trimetrexate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 42333 | Trimetrexate | Designated preferred name (PT) | NO | |
RxCUI: 42333 | Trimetrexate | Full form of descriptor (FN) | NO | |
RxCUI: 42333 | Trimetrexate | Designated preferred name (PT) | NO | |
RxCUI: 423330 | pholcodine 5 MG / pseudoephedrine HCl 20 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423330 | pholcodine 5 MG / pseudoephedrine HCl 20 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 423330 | pholcodine 5 MG / pseudoephedrine HCl 20 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 423350 | sodium benzoate 200 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423351 | sodium benzoate 80 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423352 | clenbuterol 0.002 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423353 | camphoric acid 1-methyl ester 20 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423358 | magnesium gluconogluceptate 200 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423360 | ambroxol 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423369 | oxyquinoline 0.05 MG/ML / sodium tartrate 150 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423370 | betamethasone 0.05 MG/ML / loratadine 1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423406 | bromopride 1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423410 | calcium bromide 15 MG/ML / calcium lactate 40 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423412 | camphoric acid 1-methyl ester 40 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423420 | ambroxol 6 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423420 | ambroxol 6 MG/ML Oral Solution | Designated preferred name (PT) | NO | |
RxCUI: 423420 | ambroxol 6 MG/ML Oral Solution | Full form of descriptor (FN) | NO | |
RxCUI: 423427 | trimetazidine 20 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423440 | camphor 1 MG/ML / lidocaine 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42345 | Apolipoprotein A-I | Designated preferred name (PT) | NO | |
RxCUI: 42345 | Apolipoprotein A-I | Full form of descriptor (FN) | NO | |
RxCUI: 42346 | Apolipoprotein A-II | Designated preferred name (PT) | NO | |
RxCUI: 42346 | Apolipoprotein A-II | Full form of descriptor (FN) | NO | |
RxCUI: 42347 | Bupropion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 42347 | Bupropion | Designated preferred name (PT) | YES | |
RxCUI: 42347 | Bupropion | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 42347 | Bupropion | Full form of descriptor (FN) | YES | |
RxCUI: 42347 | Bupropion | Designated preferred name (PT) | YES | |
RxCUI: 42347 | Bupropion | Full form of descriptor (FN) | YES | |
RxCUI: 42348 | canthaxanthin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 42351 | Lithium carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 42351 | Lithium carbonate | Designated preferred name (PT) | YES | |
RxCUI: 42351 | Lithium carbonate | Full form of descriptor (FN) | YES | |
RxCUI: 42351 | Lithium carbonate | Designated preferred name (PT) | YES | |
RxCUI: 42351 | Lithium carbonate | Full form of descriptor (FN) | YES | |
RxCUI: 42352 | Antigen of Human immunodeficiency virus protein 24 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42352 | Antigen of Human immunodeficiency virus protein 24 | Full form of descriptor (FN) | NO | |
RxCUI: 42352 | Antigen of Human immunodeficiency virus protein 24 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42352 | Antigen of Human immunodeficiency virus protein 24 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42352 | Antigen of Human immunodeficiency virus protein 24 | Designated preferred name (PT) | NO | |
RxCUI: 423521 | vitamin B6 12 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42355 | Fluvoxamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 42355 | Fluvoxamine | Designated preferred name (PT) | YES | |
RxCUI: 42355 | Fluvoxamine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 42355 | Fluvoxamine | Full form of descriptor (FN) | YES | |
RxCUI: 42355 | Fluvoxamine | Designated preferred name (PT) | YES | |
RxCUI: 42355 | Fluvoxamine | Full form of descriptor (FN) | YES | |
RxCUI: 423569 | vit-B1 0.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423569 | vit-B1 0.5 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 423569 | vit-B1 0.5 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 423585 | lidocaine 10 MG/ML / methylbenzethonium 1 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423586 | triclosan 4 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423587 | triclosan 1 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42359 | Tocainide | Full form of descriptor (FN) | NO | |
RxCUI: 42359 | Tocainide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 42359 | Tocainide | Designated preferred name (PT) | NO | |
RxCUI: 42359 | Tocainide | Full form of descriptor (FN) | NO | |
RxCUI: 42359 | Tocainide | Designated preferred name (PT) | NO | |
RxCUI: 423595 | triclosan 5.5 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423597 | polidocanol 80 MG/ML / ZNO 80 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423597 | polidocanol 80 MG/ML / ZNO 80 MG/ML Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42360 | Antiphospholipid anticoagulant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42360 | Antiphospholipid anticoagulant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42360 | Antiphospholipid anticoagulant | Designated preferred name (PT) | NO | |
RxCUI: 42360 | Antiphospholipid anticoagulant | Full form of descriptor (FN) | NO | |
RxCUI: 42361 | Crotaline | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42361 | Crotaline | Designated preferred name (PT) | NO | |
RxCUI: 42361 | Crotaline | Full form of descriptor (FN) | NO | |
RxCUI: 423616 | menthol 1.5 MG/ML / simethicone 50 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423617 | menthol 5 MG/ML / simethicone 50 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423628 | glycerin 120 MG/ML / petrolatum 40 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423629 | glycerin 50 MG/ML / petrolatum 50 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42363 | TCR g/d - T-cell receptor gamma/delta | Designated preferred name (PT) | NO | |
RxCUI: 42363 | TCR g/d - T-cell receptor gamma/delta | Full form of descriptor (FN) | NO | |
RxCUI: 42363 | TCR g/d - T-cell receptor gamma/delta | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 423630 | glycerin 120 MG/ML / lactic acid 50 MG/ML / petrolatum 40 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42364 | TCR a/b - T-cell receptor alpha/beta | Designated preferred name (PT) | NO | |
RxCUI: 42364 | TCR a/b - T-cell receptor alpha/beta | Full form of descriptor (FN) | NO | |
RxCUI: 42364 | TCR a/b - T-cell receptor alpha/beta | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42366 | Transglycosylase | Designated preferred name (PT) | NO | |
RxCUI: 42366 | Transglycosylase | Full form of descriptor (FN) | NO | |
RxCUI: 42366 | Transglycosylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 42368 | Encainide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 42368 | Encainide | Designated preferred name (PT) | NO | |
RxCUI: 42368 | Encainide | Full form of descriptor (FN) | NO | |
RxCUI: 42368 | Encainide | Designated preferred name (PT) | NO | |
RxCUI: 42368 | Encainide | Full form of descriptor (FN) | NO | |
RxCUI: 423681 | decamethrin 0.2 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423683 | salicylic acid 1 MG/ML / triamcinolone 0.2 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423684 | zinc pyrithione 9.5 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423702 | calamine 60 MG/ML / resorcinol 60 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423704 | phenothrin 1.2 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423705 | phenothrin 3 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423713 | ensulizole 10 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423714 | ensulizole 35 MG/ML / ZNO 39.2 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423714 | ensulizole 35 MG/ML / ZNO 39.2 MG/ML Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 423716 | permethrin 45.8 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42372 | Pseudomonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 42372 | Pseudomonic acid | Designated preferred name (PT) | YES | |
RxCUI: 42372 | Pseudomonic acid | Full form of descriptor (FN) | YES | |
RxCUI: 42372 | Pseudomonic acid | Designated preferred name (PT) | YES | |
RxCUI: 42372 | Pseudomonic acid | Full form of descriptor (FN) | YES | |
RxCUI: 42372 | Pseudomonic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 42372 | Pseudomonic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 42375 | Leuprorelin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 42375 | Leuprorelin | Designated preferred name (PT) | YES | |
RxCUI: 42375 | Leuprorelin | Designated preferred name (PT) | YES | |
RxCUI: 42375 | Leuprorelin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 42375 | Leuprorelin | Full form of descriptor (FN) | YES | |
RxCUI: 42375 | Leuprorelin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 42375 | Leuprorelin | Full form of descriptor (FN) | YES | |
RxCUI: 423803 | lanolin 10 MG/ML / mineral oil 40 MG/ML / petrolatum 100 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423836 | acetic acid 40 MG/ML / pyrethrins 3 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423837 | sulfacetamide 100 MG/ML / vitamin B6 22 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 42386 | immunoglobulins, intravenous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 423906 | budesonide 0.25 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423924 | lidocaine 25 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423928 | benzyl benzoate 100 MG/ML / monosulfiram 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423929 | polidocanol 80 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423931 | lidocaine 20 MG/ML / lindane 10 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423935 | allethrin 2 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423992 | chloroxylenol 3 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423994 | chlorhexidine 1 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423996 | chloroxylenol 10 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 423997 | minoxidil 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 423997 | minoxidil 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 423997 | minoxidil 5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |